Business

December 2, 2013

BioDelivery Sciences gets good news from FDA

BioDelivery Sciences International announced Monday that it expects to begin Phase 3 clinical trials for its drug Clonidine by the first quarter of next year.

Related content

Comments

Editor's Choice Videos